Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023)

Mira Pharmaceuticals' (MIRA) quarterly Debt Ratio came in at 0.47 in Q2 2023, up 203.96% quarter-over-quarter from 0.16 in Q4 2022.

Mira Pharmaceuticals (MIRA) Debt Ratio (2022 - 2023) Analysis & Trends

Mira Pharmaceuticals has disclosed Debt Ratio across 2 years of filings, most recently posting 0.47 for Q2 2023.

Debt Ratio for Q2 2023 came in at 0.47, changed N/A year-over-year; the trailing twelve-month figure through Jun 2023 was 0.47 (changed N/A YoY), and the FY2022 annual result was 0.16, changed N/A from the prior year.
Debt Ratio came in at 0.47 for Q2 2023 at Mira Pharmaceuticals, up from 0.16 in the prior quarter.
In the past five years, Debt Ratio ranged from a high of 0.47 in Q2 2023 to a low of 0.16 in Q4 2022.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)	Debt Ratio (Qtr)
1	Gsk	93,699,046.73 Bn	93,699,041.77 Bn	7.76 Bn	-0.22
2	Eli Lilly	1,012.06 Bn	1,006.77 Bn	16.22 Bn	0.37
3	Johnson & Johnson	560.67 Bn	538.62 Bn	15.96 Bn	0.27
4	AbbVie	402.20 Bn	392.85 Bn	10.78 Bn	0.47
5	Merck	298.59 Bn	292.94 Bn	12.09 Bn	0.38
6	Amgen	188.77 Bn	176.74 Bn	5.87 Bn	0.62
7	Gilead Sciences	160.22 Bn	152.49 Bn	5.52 Bn	0.39
8	Pfizer	148.19 Bn	135.42 Bn	-1.21 Bn	0.31
9	Bristol Myers Squibb	116.72 Bn	106.26 Bn	8.07 Bn	0.51
10	Mira Pharmaceuticals	23.69 Mn	12.66 Mn	-	-

Download Data

Date	Value
Jun 30, 2023	0.47
Dec 31, 2022	0.16